Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter-defibrillator therapy: comment—Authors’ reply

EP Europace Journal

13 November 2018
Organised by: Logo
ESC Journals

Contributors

Ammar M Killu
Ammar M Killu

Author

Mayo Clinic Rochester , United States of America

ESC 365 is supported by